Skip to main content
Clinical Trials/KCT0001502
KCT0001502
Completed
未知

Comparison of predictive performance between modified Marsh propofol model and Schnider propofol model in underweight patients

Asan Medical Center0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Asan Medical Center
Enrollment
30
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. body mass index (BMI) \< 18\.5 (kg/m2\)
  • 2\. Hemoglobin \> 9 (mg/dl)
  • 3\. Patients undergoing elective surgery under general anesthesia

Exclusion Criteria

  • 1\. Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive urine pregnancy test
  • 2\. Patients with known hypersensitivity to propofol or to any of the excipients
  • 3\. Clinically significant impairment of cardiovascular, respiratory and renal function
  • 4\. Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
To assess the predictive ability of Echocardiographic parameter of heart and carotid artery ,large vein in abdomen ultrasonosonography parameter to predict which patient need intravenous fluid in IC
CTRI/2021/10/037077AIIMS JODHPUR
Active, not recruiting
Not Applicable
Estudio comparativo de dos métodos para predecir el uso de co-receptores por el virus de la inmunodeficiencia 1 (HIV-1): el ensayo fenotípico (Trofile ESTA®) y la respuesta virológica a corto plazo a un antagonista de CCR5.Infección por el Virus de la Inmunodeficiencia Humana tipo-1 (VIH-1).El antirretroviral maraviroc pertenece a un grupo de medicamentos llamados antagonistas del CCR5 e impide la entrada del VIH-1 en las células sanguíneas, bloqueando el receptor CCR5 que el VIH utiliza para poder entrar en estas células.
EUCTR2008-007208-28-ESAsociación para el Estudio de las Enfermedades Infecciosas
Unknown
Not Applicable
Comparing the 5 year overall survival data (observed) of operable cancer patients population from India with the prediction of overall survival of these patients as suggested by online tool called PREDICT (version 2.0)Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
CTRI/2020/06/025753Tata Memorial Centre
Completed
Not Applicable
Comparison of Intraocular lens power calculation formulas in patients underwent cataract surgery after acute primary angle closure attackDiseases of the eye and adnexa
KCT0007343Ewha Womans University Medical Center104
Completed
Not Applicable
Comparison of prediction model by vital signs for in-hospital mortality in emergency patientsemergency patients
JPRN-UMIN000032365ational Hospital Organization Kumamoto Medical Center16,459